Ibopamine in chronic congestive heart failure: Hemodynamic and neurohumoral effects
- 29 May 1991
- journal article
- review article
- Published by Elsevier in American Journal Of Medicine
- Vol. 90 (5), S43-S49
- https://doi.org/10.1016/0002-9343(91)90273-z
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inhibition of Aldosterone Secretion by Dopamine, Ibopamine, and Dihydroergotoxine in Patients with Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1989
- Sequential neurohumoral measurements in patients with congestive heart failureAmerican Heart Journal, 1988
- Neurohumoral and hemodynamic changes in congestive heart failure: Lack of correlation and evidence of compensatory mechanismsAmerican Heart Journal, 1988
- Ibopamine in Congestive Heart Failure Refractory to Digitalis, Diuretics, and CaptoprilThe Journal of Clinical Pharmacology, 1986
- Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathyClinical Cardiology, 1985
- Pathophysiology of congestive heart failureThe American Journal of Cardiology, 1985
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockadeThe American Journal of Cardiology, 1984
- Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1983
- Hemodynamic Effects of Ibopamine in Patients with Idiopathic Congestive CardiomyopathyJournal of Cardiovascular Pharmacology, 1983